GO:0004471 malate dehydrogenase (decarboxylating) (NAD+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004471 describes the NAD+-dependent decarboxylating malate dehydrogenase activity that converts (S)-malate to pyruvate, CO2, and NADH.
• This activity is also known as NAD-malic enzyme (NAD-ME) and is distinct from non-decarboxylating malate dehydrogenases.
• NAD-ME is widely distributed across plants, animals, and microorganisms, where it plays roles in C4 photosynthesis, mitochondrial metabolism, and parasite energy metabolism [2,4,6].
• The enzyme is a target for understanding metabolic reprogramming in cancer, diabetes, and infectious diseases.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise interrogation of NAD-ME function in health and disease.
• EDITGENE provides end-to-end services for generating and screening NAD-ME-related cell models.
Description
Malate dehydrogenase (decarboxylating) (NAD+) activity, encoded by GO:0004471, catalyzes the oxidative decarboxylation of (S)-malate to pyruvate, CO2, and NADH. This activity is commonly referred to as NAD-malic enzyme (NAD-ME) and is a key component of the malate valve and mitochondrial metabolism. Unlike canonical malate dehydrogenases that produce oxaloacetate, NAD-ME directly yields pyruvate, linking malate oxidation to pyruvate production and NADH generation. The enzyme is found in diverse organisms, from parasitic protozoa to plants and mammals, where it supports energy metabolism and biosynthetic pathways [2,4,6]. In C4 plants, NAD-ME is essential for the decarboxylation step that concentrates CO2 for photosynthesis. In humans, dysregulation of NAD-ME activity has been implicated in metabolic disorders and cancer, making it a potential therapeutic target. Understanding its mechanism, regulation, and role in disease is therefore of broad interest to researchers in cell biology, oncology, and parasitology.
malate dehydrogenase (decarboxylating) (NAD+) activity At A Glance
| GO ID | GO:0004471 |
|---|---|
| GO term | malate dehydrogenase (decarboxylating) (NAD+) activity |
| Ontology | molecular_function |
| Synonym | malate dehydrogenase (decarboxylating) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; 'malic' enzyme; NAD-linked malic enzyme; NAD-malic enzyme activity; NAD-specific malic enzyme; (S)-malate:NAD+ oxidoreductase (decarboxylating); (S)-malate:NAD+ oxidoreductase (oxaloacetate-decarboxylating) |
| Major function | Catalyzes the oxidative decarboxylation of (S)-malate to pyruvate, CO2, and NADH |
| Reaction | (S)-malate + NAD+ = pyruvate + CO2 + NADH |
| Cofactor | NAD+ |
| Substrate | (S)-malate |
| Product | pyruvate, CO2, NADH |
What Is GO:0004471?
GO:0004471 defines the molecular function of catalyzing the reaction: (S)-malate + NAD+ = pyruvate + CO2 + NADH. This activity requires NAD+ as an electron acceptor and releases CO2, distinguishing it from malate dehydrogenases that produce oxaloacetate. The term encompasses synonyms such as 'malic' enzyme, NAD-linked malic enzyme, and NAD-specific malic enzyme, reflecting its historical characterization in various organisms [1,6].
Why Is malate dehydrogenase (decarboxylating) (NAD+) activity Important in Cell Biology?
NAD-malic enzyme (NAD-ME) is central to carbon flux in mitochondria and plastids, influencing energy production, anaplerosis, and redox balance. Its activity is critical for C4 photosynthesis in plants and for the survival of parasites that rely on malate fermentation [4,6]. In humans, altered NAD-ME expression is associated with metabolic diseases such as diabetes and with tumor metabolic reprogramming, highlighting its potential as a biomarker and drug target.
• Supports C4 photosynthesis by decarboxylating malate to provide CO2 to Rubisco.
• Plays a key role in mitochondrial energy metabolism and redox homeostasis.
• Essential for the survival of certain parasites, including Tritrichomonas foetus and Hymenolepis microstoma [2,4].
• Contributes to insulin secretion and glucose homeostasis in pancreatic beta cells.
• Implicated in cancer metabolism, where it may support tumor growth under hypoxia.
• Target for antiparasitic drug development [2,4].
• Provides a model for studying enzyme evolution and bifunctional activities [3,5].
• Enables metabolic engineering of crops for improved photosynthesis.
• Serves as a marker for mitochondrial dysfunction in diabetes.
• Facilitates research on malate valves and inter-organelle communication.
What Happens During malate dehydrogenase (decarboxylating) (NAD+) activity?
Substrate Binding and Oxidative Decarboxylation
In simple terms: The enzyme grabs malate and NAD+, then removes CO2 to make pyruvate.
NAD-ME binds (S)-malate and NAD+ in a sequential ordered mechanism. The enzyme first oxidizes malate to oxaloacetate, which is then decarboxylated to pyruvate, with NADH and CO2 released. This reaction is distinct from the non-decarboxylating malate dehydrogenase reaction that yields oxaloacetate.
Role in C4 Photosynthesis
In simple terms: In C4 plants, this enzyme helps concentrate CO2 for sugar production.
In NAD-ME subtype C4 plants, the enzyme is localized in mitochondria of bundle sheath cells, where it decarboxylates malate transported from mesophyll cells, releasing CO2 for fixation by Rubisco. This process is essential for efficient photosynthesis under high light and temperature.
Mitochondrial Energy Metabolism
In simple terms: It helps mitochondria produce energy from malate.
In mitochondria, NAD-ME provides pyruvate for the TCA cycle and generates NADH for oxidative phosphorylation. This contributes to ATP production and maintains redox balance.
Parasite Metabolism
In simple terms: Some parasites use this enzyme to survive without oxygen.
In anaerobic parasites such as Tritrichomonas foetus and Hymenolepis microstoma, NAD-ME is a key enzyme in malate fermentation, producing pyruvate, acetate, and ATP [2,4]. Its unique properties make it a potential drug target.
Key Genes Involved in GO:0004471 malate dehydrogenase (decarboxylating) (NAD+) activity
The following genes and proteins are directly associated with NAD-malic enzyme activity or its regulation across species.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ME1 (human) | Cytosolic NADP-dependent malic enzyme | Not directly GO:0004471 but related; studied in cancer metabolism |
| ME2 (human) | Mitochondrial NAD-dependent malic enzyme | Directly catalyzes GO:0004471; target for metabolic disorders |
| ME3 (human) | Mitochondrial NADP-dependent malic enzyme | Related activity; involved in glutamine metabolism |
| NAD-ME1 (Arabidopsis) | Mitochondrial NAD-malic enzyme subunit | Model for C4 photosynthesis and malate valve [1,6] |
| NAD-ME2 (Arabidopsis) | Mitochondrial NAD-malic enzyme subunit | Essential for C4 cycle in NAD-ME plants |
| ZmNAD-ME (maize) | C4 photosynthesis decarboxylase | Key enzyme in NAD-ME subtype |
| TfME (Tritrichomonas foetus) | Hydrogenosomal NAD-malic enzyme | Drug target in parasites |
| HmME (Hymenolepis microstoma) | Mitochondrial NAD-malic enzyme | Parasite energy metabolism |
| RsME (Rhodopseudomonas sphaeroides) | Bifunctional tartrate dehydrogenase-malic enzyme | Model for enzyme evolution |
| PcME (pea) | Chloroplast NADP-malic enzyme | Related to NAD-ME evolution |
| MOD1 (Arabidopsis) | NAD-malic enzyme involved in fatty acid synthesis | Links malate metabolism to lipid production |
| MDH (various) | Malate dehydrogenase (non-decarboxylating) | Often co-studied with NAD-ME |
| PDH (various) | Pyruvate dehydrogenase | Downstream of NAD-ME product pyruvate |
| PC (various) | Pyruvate carboxylase | Competes with NAD-ME for pyruvate |
| GOT (various) | Glutamate oxaloacetate transaminase | Interconverts malate and aspartate |
| DIC (various) | Dicarboxylate carrier | Transports malate across mitochondrial membrane |
| OGC (various) | Oxoglutarate carrier | Malate/oxoglutarate exchange |
| NAD-ME (Cestoda) | Parasite malic enzyme | Anthelmintic target |
How Is malate dehydrogenase (decarboxylating) (NAD+) activity Regulated?
NAD-ME activity is regulated at multiple levels. In plants, expression is controlled by light and developmental cues, with isoforms specific to C4 photosynthesis. In mammals, ME2 is regulated by nutrient availability and hormones such as insulin. Allosteric regulation by fumarate and other metabolites has been reported. In parasites, enzyme activity is modulated by redox state and substrate availability.
malate dehydrogenase (decarboxylating) (NAD+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ME2 | Cancer metabolism, diabetes | ME2 knockout and overexpression in cancer cell lines |
| ME2 | Diabetic cardiomyopathy | Cardiomyocytes from diabetic animal models |
| TfME | Trichomoniasis | Tritrichomonas foetus culture with enzyme inhibitors |
| HmME | Cestode infection | Hymenolepis microstoma in vitro assays |
| NAD-ME1/2 | C4 photosynthesis efficiency | Arabidopsis and maize mutants |
Diabetes and Metabolic Disorders
Altered NAD-ME activity has been observed in the myocardium of rabbits with alloxan-induced diabetes, suggesting a role in diabetic cardiomyopathy. The enzyme's contribution to NADH production and pyruvate supply may influence insulin secretion and glucose homeostasis.
Cancer Metabolism
ME2, the mitochondrial NAD-dependent malic enzyme, supports glutamine metabolism and redox balance in cancer cells. Its upregulation has been linked to tumor growth and survival under hypoxia, making it a potential therapeutic target.
Parasitic Infections
NAD-ME is essential for the energy metabolism of parasites such as Tritrichomonas foetus and Hymenolepis microstoma, which lack functional mitochondria or rely on anaerobic fermentation [2,4]. Inhibitors of this enzyme could serve as antiparasitic drugs.
From malate dehydrogenase (decarboxylating) (NAD+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ME2 loss affect cancer cell proliferation? | ME2 knockout in HCT116 or HeLa cells |
| Does ME2 mutation alter insulin secretion? | Point mutation knock-in in pancreatic beta cells |
| Can NAD-ME be targeted in parasites? | Knockout in Tritrichomonas foetus |
| How does NAD-ME contribute to C4 photosynthesis? | Overexpression in C3 plants |
| What is the subcellular localization of NAD-ME? | Tagged knock-in with GFP in Arabidopsis |
| Does NAD-ME interact with other metabolic enzymes? | Knock-in with affinity tags for proteomics |
How to Study the malate dehydrogenase (decarboxylating) (NAD+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH absorbance assay | Enzyme activity | Kinetic characterization of NAD-ME |
| RNA-seq | Transcript levels | Expression profiling in disease models |
| LC-MS metabolomics | Metabolite flux | Pathway analysis in cancer cells |
| CRISPR knockout screen | Gene essentiality | Identifying synthetic lethality |
| Western blot | Protein abundance | Validating knockout efficiency |
| Immunofluorescence | Subcellular localization | Mitochondrial targeting |
| Co-immunoprecipitation | Protein interactions | Identifying binding partners |
| Enzyme-linked assay | Inhibitor efficacy | Drug screening |
Enzymatic Activity Assays
NAD-ME activity is typically measured spectrophotometrically by monitoring NADH production at 340 nm using malate and NAD+ as substrates [1,7]. This method is widely used to characterize enzyme kinetics and inhibitor effects.
Gene Expression Analysis
RNA-seq and qPCR are used to quantify ME2 mRNA levels across tissues and conditions, revealing regulation in diabetes and cancer. In plants, transcript profiling has elucidated C4-specific isoforms.
Proteomics and Metabolomics
Mass spectrometry-based proteomics can identify NAD-ME post-translational modifications, while metabolomics measures flux through malate and pyruvate. These approaches are powerful for studying metabolic reprogramming.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify synthetic lethal interactions with ME2 loss, uncovering metabolic vulnerabilities in cancer. Such screens are instrumental for target discovery.
How CRISPR Can Be Used to Study GO:0004471 malate dehydrogenase (decarboxylating) (NAD+) activity
Knockout
CRISPR-Cas9 knockout of ME2 or NAD-ME genes in cell lines and model organisms enables loss-of-function studies to assess metabolic dependencies and disease phenotypes. Knockout models are essential for validating drug targets.
Point Mutation
Introducing specific point mutations (e.g., in catalytic residues) via CRISPR base editing or HDR allows fine-tuning of enzyme activity and studying structure-function relationships.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) at the endogenous locus facilitates real-time imaging and proteomic analysis of NAD-ME. This approach preserves native regulation.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of NAD-ME can model gain-of-function states observed in cancer and metabolic disorders. Overexpression in C3 plants can enhance photosynthetic efficiency.
How EDITGENE Supports malate dehydrogenase (decarboxylating) (NAD+) activity Research
Researchers studying malate dehydrogenase (decarboxylating) (NAD+) activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for malate dehydrogenase (decarboxylating) (NAD+) activity research.
Frequently Asked Questions About malate dehydrogenase (decarboxylating) (NAD+) activity
What is malate dehydrogenase (decarboxylating) (NAD+) activity?
It is the enzyme activity defined by GO:0004471 that converts (S)-malate to pyruvate, CO2, and NADH, also known as NAD-malic enzyme.
What genes are involved in malate dehydrogenase (decarboxylating) (NAD+) activity?
Key genes include ME2 in humans, NAD-ME1 and NAD-ME2 in plants, and homologs in parasites such as Tritrichomonas foetus [4,6,8].
What is the difference between malate dehydrogenase and malic enzyme?
Malate dehydrogenase produces oxaloacetate, while malic enzyme (GO:0004471) decarboxylates malate to pyruvate.
How is NAD-malic enzyme regulated?
It is regulated by light, nutrients, hormones, and allosteric effectors like fumarate [1,6,8].
What diseases are associated with NAD-malic enzyme?
Diabetes, cancer, and parasitic infections have been linked to altered NAD-ME activity [2,4,8].
How can I study NAD-malic enzyme using CRISPR?
CRISPR knockout, knock-in, point mutation, and overexpression models allow functional studies.
What methods measure NAD-malic enzyme activity?
Spectrophotometric NADH assays, metabolomics, and RNA-seq are commonly used [1,7].
Is NAD-malic enzyme a drug target?
Yes, it is considered a target for cancer, diabetes, and antiparasitic therapies [4,8].
What is the role of NAD-malic enzyme in C4 photosynthesis?
It decarboxylates malate to provide CO2 to Rubisco in bundle sheath cells.
Where can I get custom CRISPR models for NAD-malic enzyme?
EDITGENE offers knockout, knock-in, point mutation, and overexpression services for NAD-ME genes.
Conclusion
NAD-malic enzyme (GO:0004471) is a versatile metabolic enzyme with critical roles in photosynthesis, mitochondrial metabolism, and parasite survival. Its dysfunction is linked to diabetes, cancer, and infectious diseases, making it a compelling target for basic and translational research. CRISPR-based models and EDITGENE's services empower researchers to dissect its mechanisms and develop novel therapeutics.
References
- 1. Selinski J et al.. 2019. Malate valves: old shuttles with new perspectives.. Plant Biol (Stuttg) 21 Suppl 1(Suppl Suppl 1):21-30 PMID: 29933514
- 2. Fioravanti CF. 1982. Mitochondrial malate dehydrogenase, decarboxylating ("malic" enzyme) and transhydrogenase activities of adult Hymenolepis microstoma (Cestoda).. J Parasitol 68(2):213-20 PMID: 7077455
- 3. Giffhorn F et al.. 1983. Purification and characterization of a bifunctional L-(+)-tartrate dehydrogenase-D-(+)-malate dehydrogenase (decarboxylating) from Rhodopseudomonas sphaeroides Y.. J Bacteriol 155(1):281-90 PMID: 6345505
- 4. Hrdý I et al.. 1993. Purification and partial characterization of malate dehydrogenase (decarboxylating) from Tritrichomonas foetus hydrogenosomes.. Parasitology 107 ( Pt 4):379-85 PMID: 8278219
- 5. Fickenscher K et al.. 1987. Amino acid sequence similarity between malate dehydrogenases (NAD) and pea chloroplast malate dehydrogenase (NADP).. Eur J Biochem 168(3):653-8 PMID: 3665938
- 6. Maier A et al.. 2011. Malate decarboxylases: evolution and roles of NAD(P)-ME isoforms in species performing C(4) and C(3) photosynthesis.. J Exp Bot 62(9):3061-9 PMID: 21459769
- 7. Hatch MD et al.. 1982. Determination of NAD Malic Enzyme in Leaves of C(4) Plants : EFFECTS OF MALATE DEHYDROGENASE AND OTHER FACTORS.. Plant Physiol 69(2):483-91 PMID: 16662234
- 8. Dagaeva LN. 1975. [Activity of NAD- and NADP-dependent malate dehydrogenase isoenzymes in the myocardium of rabbits with alloxan diabetes].. Biull Eksp Biol Med 80(7):43-5 PMID: 6094
